BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 6757466)

  • 1. Immunoperoxidase staining of acid phosphatase in human prostatic tissue.
    Lippert MC; Bensimon H; Javadpour N
    J Urol; 1982 Nov; 128(5):1114-6. PubMed ID: 6757466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transitional cell carcinoma of the prostate.
    Algaba F; Santaularia JM; Lamas M; Ayala G
    Eur Urol; 1985; 11(2):87-90. PubMed ID: 3891355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunodiagnosis by prostatic acid phosphatase to differentiate primary male breast cancer from metastatic prostate cancer.
    Kumar PP; Good RR; Newland JR
    J Natl Med Assoc; 1986 Aug; 78(8):782-4, 786. PubMed ID: 3531533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemistry of prostatic acid phosphatase.
    Yam LT; Janckila AJ; Lam WK; Li CY
    Prostate; 1981; 2(1):97-107. PubMed ID: 7024961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis of carcinoid-like metastatic prostatic carcinoma by an immunoperoxidase method.
    Ansari MA; Pintozzi RL; Choi YS; Ladove RF
    Am J Clin Pathol; 1981 Jul; 76(1):94-8. PubMed ID: 7020410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostatic origin of tumors. An immunohistochemical study.
    Nadji M; Tabei SZ; Castro A; Chu TM; Morales AR
    Am J Clin Pathol; 1980 Jun; 73(6):735-9. PubMed ID: 6156593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relation of prostatic acid phosphatase and prostate specific antigen with tumour grade in prostatic adenocarcinoma: an immunohistochemical study.
    Ersev A; Ersev D; Turkeri L; Ilker Y; Simsek F; Kullu S; Akdas A
    Prog Clin Biol Res; 1990; 357():129-34. PubMed ID: 1699237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical localization of prostate-specific acid phosphatase and prostate-specific antigen in stage A2 adenocarcinoma of the prostate: prognostic implications.
    Epstein JI; Eggleston JC
    Hum Pathol; 1984 Sep; 15(9):853-9. PubMed ID: 6381284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epithelial markers in prostatic, bladder, and colorectal cancer: an immunoperoxidase study of epithelial membrane antigen, carcinoembryonic antigen, and prostatic acid phosphatase.
    Heyderman E; Brown BM; Richardson TC
    J Clin Pathol; 1984 Dec; 37(12):1363-9. PubMed ID: 6392348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoperoxidase localization of prostatic acid phosphatase in prostatic carcinoma with sarcomatoid changes.
    OrdoƱez NG; Ayala AG; von Eschenbach AC; Mackay B; Hanssen G
    Urology; 1982 Feb; 19(2):210-4. PubMed ID: 7036494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An immunoperoxidase technique to aid in the differential diagnosis of prostatic carcinoma.
    Fishleder A; Tubbs RR; Levin HS
    Cleve Clin Q; 1981; 48(3):331-5. PubMed ID: 7028321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urethral metastasis from prostatic carcinoma as diagnosed by immunoperoxidase technique using prostate-specific antigen and prostate-specific acid phosphatase.
    Koh E; Sekii K; Namiki M; Fujioka H; Onoue K; Sakurai M; Sonoda T
    Eur Urol; 1987; 13(1-2):142-4. PubMed ID: 2438138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of commercial immunoperoxidase kits for prostatic specific antigen and prostatic specific acid phosphatase.
    Svanholm H
    Acta Pathol Microbiol Immunol Scand A; 1986 Jan; 94(1):7-12. PubMed ID: 2421532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical acid phosphatase level and tumor grade in prostatic carcinoma.
    Bentz MS; Cohen C; Demers LM; Budgeon LR
    Arch Pathol Lab Med; 1982 Sep; 106(9):476-80. PubMed ID: 6287961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoperoxidase demonstration of prostatic acid phosphatase in aspiration biopsy cytology (ABC).
    Keshgegian AA; Kline TS
    Am J Clin Pathol; 1984 Nov; 82(5):586-9. PubMed ID: 6388312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostatic cancer presenting as metastatic adenocarcinoma of undetermined origin. Immunodiagnosis by prostatic acid phosphatase.
    Yam LT; Winkler CF; Janckila AJ; Li CY; Lam KW
    Cancer; 1983 Jan; 51(2):283-7. PubMed ID: 6336978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate-specific acid phosphatase immunoreactivity in adenocarcinomas of the urinary bladder.
    Epstein JI; Kuhajda FP; Lieberman PH
    Hum Pathol; 1986 Sep; 17(9):939-42. PubMed ID: 2428729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostatic mucinous adenocarcinoma.
    Hsueh Y; Tsung SH
    Urology; 1984 Dec; 24(6):626-7. PubMed ID: 6095509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High grade prostatic adenocarcinoma with a partly intraductal growth pattern producing a mimic of urothelial carcinoma in situ.
    Shaw EC; Oxley JD; Varma M; Theaker J
    J Clin Pathol; 2013 Aug; 66(8):729-31. PubMed ID: 23268319
    [No Abstract]   [Full Text] [Related]  

  • 20. Prostatic acid phosphatase in cloacal derivatives.
    Fernandez PL; Gomez M; Caballero T; Medina T; Aguilar D
    Am J Surg Pathol; 1992 May; 16(5):526-7. PubMed ID: 1599030
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.